pharynx cancer: A primary or metastatic malignant neoplasm that affects the pharynx.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
292 |
4. Check minimum number of eventsNone |
292 |
5. Include endpointsNone |
292 |
6. Filter based on genotype QC (FinnGen only) |
275 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D10
- Name in latin
- Neoplasma benignum pharyngis non specificatum
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Pharynx, unspecified
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of mouth and pharynx
- Benign neoplasms
- Neoplasms
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1705 | 921 | 768 |
| Only index persons | 1541 | 851 | 690 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.03 | 0.02 |
| Only index persons | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 52.22 | 51.72 | 52.86 |
| Only index persons | 51.94 | 51.56 | 52.40 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 275 | 167 | 108 |
| Unadjusted period prevalence (%) | 0.06 | 0.06 | 0.05 |
| Median age at first event (years) | 56.02 | 54.03 | 59.09 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 292
- Matched controls
- 2920
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D10.9
ICD-10 Finland
Benign neoplasm: Pharynx, unspecified
+∞
307.7
268
*
ENA10
NOMESCO Finland
Biopsy of pharynx
307.5
51.9
51
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
5.7
22.9
47
95
JDB10
NOMESCO Finland
Percutaneous gastrostomy
35.5
18.3
23
7
21099
ICD-8 Finland
Benign neoplasm of buccal cavity and pharynx, Pharynx unspecified
+∞
17.9
17
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
4.7
16.9
42
100
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
15.7
16.2
26
18
EMA10
NOMESCO Finland
Biopsy of tonsil
38.2
14.6
18
5
EHA10
NOMESCO Finland
Biopsy of palate
39.4
12.3
15
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
17.3
11.8
18
11
R21
ICPC
Throat symptom/complaint
2.6
11.2
85
403
ENB00
NOMESCO Finland
Excision or exploration of lesion of pharynx
113.9
10.5
11
*
D10.09
ICD-10 Finland
Benign tumor of the lip UNS
+∞
10.5
10
*
UJC01
NOMESCO Finland
Scopy of lower throat
16.3
9.1
14
9
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
16.3
9.1
14
9
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
24.9
9.0
12
5
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
11.2
8.9
16
15
D10.19
ICD-10 Finland
Benign tumor of the tongue UNS
34.4
8.1
10
*
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
15.6
7.8
12
8
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
7.8
88
487
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
19.0
7.7
11
6
WZC00
NOMESCO Finland
Treatment plan or consultation
2.0
7.3
113
699
GBB00
NOMESCO Finland
Tracheostomy
12.4
7.1
12
10
R07.0
ICD-10 Finland
Pain in throat
3.3
6.9
27
88
EMB10
NOMESCO Finland
Tonsillectomy
3.5
6.7
23
69
UDC00
NOMESCO Finland
Ear microscopy
3.0
6.6
31
113
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
6.6
91
538
A07AA02
ATC
nystatin; oral
3.2
6.5
26
86
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
6.5
127
843
A02BC02
ATC
pantoprazole; systemic
2.0
6.5
200
1539
D10.5
ICD-10 Finland
Benign neoplasm: Other parts of oropharynx
71.3
6.5
7
*
WF002
NOMESCO Finland
Radical radiotherapy
3.6
6.4
21
61
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.2
6.4
25
82
WX402
NOMESCO Finland
General anaesthesia
2.1
6.3
69
374
C10.3
ICD-10 Finland
Malignant neoplasm: Posterior wall of oropharynx
+∞
6.3
6
*
UJF32
NOMESCO Finland
Coloscopy
2.0
6.2
82
477
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
3.8
6.1
19
53
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.7
6.1
35
142
WX110
NOMESCO Finland
Infiltration anesthesia
1.9
6.1
210
1659
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
94
474
2.45
10.78
1.7
1.5
—
—
—
0
0
165
1141
2.03
7.97
7.0
6.0
1.21
1.22
mmol/l
0.30
133
974
23
61
4.01
7.96
1.3
1.2
—
—
—
0
0
151
1055
1.89
6.65
13.4
11.8
1.12
1.21
inr
1.25
50
313
143
994
1.86
6.29
4.7
4.2
35.96
35.77
g/l
0.15
135
934
139
974
1.82
5.83
2.4
2.2
74.45
76.63
nmol/l
0.39
123
863
146
1044
1.80
5.68
6.4
5.2
1.21
1.22
mmol/l
0.59
132
950
182
1396
1.81
5.52
5.5
4.3
7.30
6.59
mmol/l
2.06
177
1289
54
282
2.12
5.38
8.4
6.6
103.98
104.29
mmol/l
0.20
54
282
74
447
1.88
4.87
1.7
1.7
515.18
459.93
pmol/l
0.71
55
382
117
841
1.65
4.10
3.7
3.0
—
—
—
0
0
109
772
1.66
4.03
3.7
3.3
2.33
2.36
mmol/l
1.20
95
684
90
606
1.70
4.03
2.5
2.6
328.73
5480.27
umol/l
2.18
74
524
33
159
2.21
4.01
1.6
1.4
—
—
—
0
0
65
405
1.78
3.81
1.3
1.3
17.59
31.70
iu/ml
1.27
19
135
285
2686
3.55
3.80
27.5
19.4
259.47
251.19
e9/l
1.09
276
2622
285
2689
3.50
3.64
27.5
19.4
4.44
4.51
e12/l
1.56
274
2615
285
2689
3.50
3.64
27.6
19.5
133.24
135.82
g/l
2.19
280
2649
143
1107
1.57
3.55
2.8
2.5
—
—
—
0
0
105
757
1.60
3.53
2.7
2.4
53.25
63.12
u/l
0.88
99
698
248
2199
1.85
3.51
6.0
4.7
2.04
1.87
mu/l
0.69
223
1991
64
406
1.74
3.51
2.8
2.6
0.95
0.82
e6/l
0.23
44
225
45
257
1.89
3.47
7.0
6.8
1.83
1.03
mmol/l
0.73
33
210
148
1162
1.55
3.41
6.1
5.9
26.83
28.26
%
0.71
134
1089
147
1153
1.55
3.40
5.8
5.7
58.72
57.04
%
0.80
133
1083
284
2685
3.11
3.36
27.8
19.4
39.99
40.38
%
0.63
267
2540
57
355
1.75
3.33
1.7
1.9
—
—
—
0
0
32
167
2.03
3.19
4.3
3.1
81.45
73.09
ng/l
0.36
25
147
211
1811
1.60
3.16
5.0
4.0
14.77
14.76
pmol/l
0.02
184
1624
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
15
56
2.77
3.11
2.1
2.3
0.32
0.36
u/ml
—
8
32
265
2422
2.02
3.10
19.2
13.2
25.56
22.57
mg/l
0.88
229
1897
170
1400
1.51
2.99
10.7
9.2
4.37
4.04
e9/l
1.10
150
1233
65
432
1.65
2.98
3.0
2.8
2.44
2.45
mmol/l
0.33
60
383
19
83
2.38
2.91
1.1
1.1
—
—
—
0
0
91
664
1.54
2.81
3.7
3.0
0.39
0.50
e6/l
0.30
71
494
58
380
1.66
2.81
3.0
2.7
1.66
2.56
e6/l
0.76
39
200
9
23
4.00
2.79
1.4
1.3
—
—
—
0
0
208
1801
1.54
2.79
4.4
3.9
14.13
11.37
mm/h
1.45
191
1640
87
631
1.54
2.75
3.0
3.1
2201.59
1232.56
ng/l
0.43
70
528
75
527
1.57
2.73
1.5
1.5
22.12
21.25
nmol/l
0.14
61
435
117
909
1.48
2.65
3.2
3.6
24.68
40.97
ng/l
1.10
81
613
18
81
2.30
2.60
1.1
1.1
—
—
—
0
0
212
1857
1.52
2.57
8.2
7.4
76.55
78.74
u/l
0.51
205
1733
104
798
1.47
2.48
2.7
3.0
28.41
32.68
u/l
1.10
99
755
41
254
1.71
2.44
1.7
1.9
—
—
—
0
0
91
684
1.48
2.39
4.5
3.8
4.33
7.27
mg/mmol
0.87
56
423
22
113
2.02
2.32
1.3
2.1
—
—
—
0
0
26
142
1.91
2.32
1.6
1.2
—
—
—
0
0
60
416
1.56
2.30
1.9
1.6
1180.50
1266.57
nmol/l
0.33
43
311
25
136
1.92
2.26
1.0
1.0
—
—
—
0
0
40
253
1.67
2.21
1.7
1.8
—
—
—
0
0
16
74
2.23
2.19
2.6
3.0
—
—
—
0
0
26
146
1.86
2.14
1.7
2.1
—
—
—
0
0
11
43
2.62
2.10
3.2
6.9
—
146.14
—
0
7
77
579
1.45
1.99
1.4
1.2
1.54
1.30
u/ml
0.12
17
157
138
1150
1.38
1.98
5.5
4.7
0.00
0.00
estimate
-0.00
27
227
7
21
3.39
1.97
1.1
1.0
—
—
—
0
0
11
45
2.50
1.95
1.4
1.4
—
—
—
0
0
18
92
2.02
1.94
1.2
2.7
1.74
1.40
g/l
0.56
11
80
248
2290
1.55
1.94
17.8
12.3
85.78
83.40
ml/min/173m2
0.90
197
1856
139
1166
1.37
1.88
4.1
3.5
0.00
0.01
estimate
0.50
26
209
11
46
2.45
1.87
1.8
2.0
127.00
125.87
g/l
—
5
30
29
177
1.71
1.84
2.6
2.6
70.70
64.40
ml/min/173m2
—
10
82
137
1152
1.36
1.81
4.2
3.5
0.00
0.00
estimate
0.50
26
240
79
609
1.41
1.77
4.1
3.8
0.00
0.00
estimate
-0.00
25
218
74
568
1.41
1.70
2.0
1.9
2.72
3.08
mg/l
0.65
63
484
54
392
1.46
1.67
1.4
1.3
14.34
7.99
u/ml
0.28
19
158
11
49
2.29
1.65
1.2
1.4
—
49.08
—
0
6
12
56
2.19
1.63
1.8
1.3
138.57
295.98
ug/g
—
7
28
19
108
1.81
1.55
2.8
2.5
0.58
0.66
%
0.77
19
108
0
43
0.00
1.53
0.0
1.2
—
1.40
—
0
15
9
38
2.41
1.47
1.3
1.6
—
—
—
0
0
27
173
1.62
1.46
5.0
2.6
4.49
4.26
kpa
0.27
27
167
72
564
1.37
1.45
2.9
2.2
—
—
—
0
0
6
22
2.76
1.44
2.0
2.0
17.18
16.07
ug/l
—
6
22
124
1055
1.30
1.42
3.1
2.5
119.94
115.75
ug/l
0.08
108
964
31
208
1.55
1.40
5.6
3.3
6.11
5.86
kpa
0.68
31
203
68
533
1.36
1.37
4.0
4.1
24.76
21.20
%
0.94
29
236
0
37
0.00
1.35
0.0
1.1
—
—
—
0
0
10
47
2.17
1.35
1.6
1.2
—
—
—
0
0
10
47
2.17
1.35
1.6
1.2
—
—
—
0
0
269
2570
1.59
1.34
12.8
10.1
24.95
26.69
u/l
1.24
261
2478
109
918
1.30
1.33
2.1
1.9
102.47
95.88
pmol/l
0.59
51
453
22
139
1.63
1.27
1.6
1.4
—
—
—
0
0
34
240
1.47
1.23
4.0
3.3
—
—
—
0
0
8
37
2.19
1.22
1.6
1.4
—
—
—
0
0
5
19
2.66
1.22
1.6
1.4
—
—
—
0
0
8
38
2.14
1.19
1.6
1.5
—
—
—
0
0
25
168
1.53
1.14
3.1
2.4
11.99
13.78
nmol/l
0.52
20
154
15
88
1.74
1.13
1.7
2.1
—
—
—
0
0
7
30
2.37
1.13
2.6
3.3
2.77
3.04
nmol/l
—
7
30
7
32
2.22
1.09
1.3
1.2
—
—
—
0
0
7
32
2.22
1.09
1.4
1.7
—
—
—
0
0
7
33
2.15
1.06
1.3
1.2
—
—
—
0
0
9
47
1.94
1.03
1.6
1.6
—
—
—
0
0
40
303
1.37
1.01
2.4
2.0
21.32
22.53
%
0.17
34
261
13
76
1.74
1.00
1.3
1.7
—
—
—
0
0
0
31
0.00
0.97
0.0
2.1
—
—
—
0
0
233
2202
1.29
0.96
7.0
5.5
41.12
39.48
mmol/mol
1.52
214
2047
11
62
1.80
0.95
1.3
1.2
—
—
—
0
0
19
126
1.54
0.94
12.6
8.6
25.15
24.58
mmol/l
0.34
19
121
245
2333
1.31
0.93
5.1
4.3
6.11
5.94
mmol/l
1.01
222
2135
17
110
1.58
0.93
8.8
3.5
53.45
47.93
%
0.41
17
110
37
284
1.35
0.87
10.9
7.5
—
—
—
0
0
33
249
1.37
0.86
2.9
2.3
74.76
31.91
u/l
0.75
25
209
6
32
1.89
0.82
1.2
1.1
—
—
—
0
0
49
399
1.27
0.77
2.6
2.9
0.69
0.72
ug/l
0.15
23
259
6
34
1.78
0.76
1.2
1.1
—
—
—
0
0
13
83
1.59
0.76
1.4
1.8
—
—
—
0
0
101
892
1.20
0.76
4.3
3.5
—
—
—
0
0
18
126
1.46
0.72
1.5
1.6
—
—
—
0
0
9
58
1.57
0.70
1.9
1.7
—
—
—
0
0
5
27
1.87
0.68
1.2
1.1
—
—
—
0
0
7
43
1.64
0.67
2.7
3.7
61.00
59.07
%
—
7
43
5
28
1.80
0.66
1.4
1.2
—
—
—
0
0
5
28
1.80
0.66
1.0
2.0
—
22.91
—
0
8
10
62
1.63
0.66
1.6
1.6
—
—
—
0
0
5
29
1.74
0.64
2.0
1.4
—
—
—
0
0
167
1561
1.16
0.61
3.3
3.2
—
—
—
0
0
0
22
0.00
0.59
0.0
2.4
—
—
—
0
0
6
36
1.68
0.57
2.8
2.0
—
—
—
0
0
6
36
1.68
0.57
1.0
1.6
0.47
0.48
nmol/l
—
6
28
9
62
1.47
0.53
1.4
1.5
—
—
—
0
0
12
83
1.46
0.52
1.8
1.9
0.44
4.79
ug/l
0.74
12
76
245
2375
1.20
0.50
4.9
4.3
4.66
4.69
mmol/l
0.19
228
2207
7
45
1.57
0.49
1.7
1.6
—
—
—
0
0
243
2356
1.19
0.48
4.8
4.3
1.44
1.49
mmol/l
0.79
223
2180
7
49
1.44
0.46
1.3
1.2
—
—
—
0
0
219
2110
1.15
0.45
23.6
16.0
15.25
14.80
%
0.51
214
2083
12
86
1.41
0.45
3.4
2.2
4343.90
3096.03
u/l
—
6
32
248
2413
1.18
0.44
5.6
4.8
2.75
2.78
mmol/l
0.22
227
2229
5
31
1.62
0.43
2.4
3.5
—
—
—
0
0
8
58
1.39
0.42
1.8
1.3
—
—
—
0
0
5
33
1.52
0.41
1.2
1.4
—
—
—
0
0
5
33
1.52
0.41
3.4
2.8
105.40
105.67
mmol/l
—
5
33
0
15
0.00
0.41
0.0
2.0
—
—
—
0
0
0
15
0.00
0.41
0.0
2.0
—
—
—
0
0
8
59
1.37
0.41
1.1
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
49
430
1.17
0.41
3.5
3.5
40.52
197.30
ng/l
1.81
38
317
5
34
1.48
0.40
1.2
1.4
—
—
—
0
0
11
80
1.39
0.39
1.4
1.7
—
180.00
—
0
5
12
89
1.36
0.38
1.8
1.5
—
—
—
0
0
171
1634
1.11
0.37
3.4
3.0
42.02
47.67
u/l
0.56
161
1527
15
117
1.30
0.36
2.5
2.4
0.09
0.21
e6/l
0.58
15
112
59
531
1.14
0.36
1.7
1.7
2.12
1.19
mg/l
1.02
42
410
6
42
1.44
0.35
1.0
1.4
—
—
—
0
0
11
82
1.35
0.34
1.4
1.3
—
—
—
0
0
6
46
1.31
0.33
1.0
1.2
—
—
—
0
0
43
381
1.15
0.32
1.6
1.5
—
—
—
0
0
10
74
1.36
0.32
1.7
1.9
—
—
—
0
0
7
53
1.33
0.31
1.4
1.5
—
—
—
0
0
11
85
1.31
0.28
2.5
2.2
848.64
308.31
ug/l
0.29
11
80
8
63
1.28
0.28
1.8
1.6
—
—
—
0
0
73
677
1.10
0.27
4.3
4.5
1.97
2.50
ug/l
0.47
65
606
11
86
1.29
0.26
1.9
1.8
—
—
—
0
0
32
283
1.15
0.26
3.1
2.0
—
—
—
0
0
9
73
1.24
0.25
1.6
1.3
—
—
—
0
0
35
313
1.13
0.24
3.4
2.2
—
—
—
0
0
71
664
1.09
0.23
2.0
1.7
1.64
1.38
mmol/l
0.99
61
564
5
40
1.25
0.22
1.4
1.3
—
99.88
—
0
8
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
0
11
0.00
0.21
0.0
2.2
—
786.27
—
0
11
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
384.60
—
0
5
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
11
89
1.25
0.21
6.0
4.5
1.54
1.58
%
0.07
11
83
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
21
184
1.15
0.19
2.9
2.4
—
19.09
—
0
9
6
51
1.18
0.19
1.8
1.7
—
—
—
0
0
14
164
0.85
0.19
1.1
1.3
142.32
175.95
iu/ml
—
6
62
8
70
1.15
0.16
1.5
1.4
—
—
—
0
0
231
2275
1.07
0.16
4.3
3.9
1.32
1.28
mmol/l
0.44
212
2092
8
73
1.10
0.16
1.3
1.6
—
—
—
0
0
12
137
0.87
0.12
1.6
1.5
—
—
—
0
0
18
163
1.11
0.11
1.8
1.2
—
36.97
—
0
13
31
291
1.07
0.10
4.6
4.5
27.82
32.23
%
2.04
17
193
5
45
1.11
0.10
1.4
1.1
12.90
14.60
u/l
—
5
36
7
66
1.06
0.08
1.6
3.4
—
4.25
—
0
5
7
84
0.83
0.07
1.9
1.6
—
—
—
0
0
32
306
1.05
0.06
1.8
1.9
1.50
1.48
%
0.05
25
267
13
131
0.99
0.00
1.8
2.8
70.77
50.24
u/ml
0.20
13
126
22
217
1.01
0.00
1.7
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
6
62
0.97
-0.00
1.0
1.4
—
—
—
0
0
7
78
0.89
-0.00
1.9
1.5
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
7
78
0.89
-0.00
1.9
1.5
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
1527.11
—
0
9
7
78
0.89
-0.00
1.9
1.5
—
—
—
0
0
0
9
0.00
-0.00
0.0
7.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
7
78
0.89
-0.00
1.9
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
27.46
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_PHARYNX_NOS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_PHARYNX_NOS | 1.166 [0.87, 1.55] | 0.296 |
| Birth year | 0.993 [0.98, 1.0] | 0.132 |
During the follow-up period (1.1.1998 — 31.12.2019), 79 out of 643 females with CD2_BENIGN_PHARYNX_NOS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_PHARYNX_NOS | 2.047 [1.56, 2.68] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.064 |
During the follow-up period (1.1.1998 — 31.12.2019), 120 out of 559 males with CD2_BENIGN_PHARYNX_NOS died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_PHARYNX_NOS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.078% | 0.443% |
| 5 | 0.59% | 2.697% |
| 10 | 1.432% | 6.434% |
| 15 | 2.974% | 12.222% |
| 20 | 5.547% | 19.808% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_PHARYNX_NOS – Benign neoplasm: Pharynx, unspecified
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data